Antibe Therapeutics Inc(Pre-Merger) ATBPF

Year End Q4 financials

[Duster340]

was june 30th last year. some insider buying before the blackout would be a good sign, but i do not expect to see any at this point. Q1 is aug/15th only 6 weeks after Q4, i do not see anything new unless we do  not get the update on the "IBD" program in Q4. Q2 is nov/15th i think just prior to the release is when  we see the stock price start to move,possibly we get a firm start date for P2.  

(the Company has selected lead and back-up candidates for its inflammatory bowel disease (“IBD”) program. These candidates are being evaluated in animal efficacy models with a patent application filing expected in the current quarter. Separately, Antibe is investigating a family of anti-inflammatory compounds that recently demonstrated promising results in an initial animal model; the Company expects to be in a position to make a more comprehensive announcement in the upcoming quarter.)